Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696252 · ClinicalTrials.gov registry record
G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator
A clinical trial, sponsored by DexCom.
- Completed
- Registry status
- 97
- Enrollment target
NCT02696252: Completed study, sponsored by DexCom.
NCT02696252 is a clinical trial that has completed, run by DexCom. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02696252 has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
Comparison of G5® Mobile Continuous Glucose Monitoring System Accuracy When Using an Automated Applicator vs. a Manual Sensor Applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-04 |
What the finished NCT02696252 record still lists
NCT02696252 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02696252 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02696252 about?
NCT02696252 is a clinical study titled "G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator". Comparison of G5® Mobile Continuous Glucose Monitoring System Accuracy When Using an Automated Applicator vs. a Manual Sensor Applicator
What is the current status of trial NCT02696252?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2016-01. Estimated completion is 2016-04.
Who is sponsoring clinical trial NCT02696252?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia